29 / 148
Informaciones
Psiquiátricas
2018 - n.º
232
29
14. Minoshima S, Foster NL, Sima AA, Frey
KA, Albin RL, Kuhl DE. Alzheimer's di-
sease versus dementia with Lewy bo-
dies: cerebral metabolic distinction
with autopsy confirmation. Ann Neurol.
2001;50:358-365.
15. Thomas AJ, Attems J, Colloby SJ, O'Brien
JT, McKeith I, Walker R, et al. Autopsy
validation of 123I-FP-CIT dopaminergic
neuroimaging for the diagnosis of DLB.
Neurology. 2017;88:276-283.
16. McKeith IG, Boeve BF, Dickson DW, Ha-
lliday G, Taylor JP, Weintraub D, et al.
Diagnosis and management of dementia
with Lewy bodies: Fourth consensus re-
port of the DLB Consortium. Neurology.
2017;89:88-100.
17. Rabinovici GD, Rosen HJ, Alkalay A,
Kornak J, Furst AJ, Agarwal N, et al.
Amyloid vs FDG-PET in the differential
diagnosis of AD and FTLD. Neurology.
2011;77:2034-2042.
ACTUALIZACIÓN DE LAS TÉCNICAS DE NEUROIMAGEN FUNCIONAL:
PET FDG Y PET AMILOIDE